Laurus Labs Share Price Target 2026, 2027, 2030, 2040, 2050

Laurus Labs Limited was established in 2005. The company makes medicines and drugs for chronic diseases like HIV, Cancer, heart attack etc. The company situated in India, does business globally as it provides the best and most accurate medicine as per requirements. In this article, we will study this company in depth.

What is Laurus Labs Ltd NSE: LAURUSLABS?

Laurus Labs Limited is an Indian pharmaceutical company that makes and sells medicines and drug ingredients. The company was established in 2005 and is situated in Hyderabad, India. It mainly makes medicines for critical diseases like cancer, HIV, heart problems, and stomach issues. The company also helps other companies develop and manufacture medicines from the early stages to large-scale production. The company is known for its top-quality medicine and has customers globally.

Laurus Labs Share Price

Laurus Labs Share Price Target 2026

The company mainly expanding API production which will help the company’s growth in present as well as in future. API means Active Pharmaceutical Ingredient, which is the main ingredient in a drug that produces the intended effects. This company develop and produce APIs, which are used to make medicines. Also, it works to improve its position in the CRAMS market and bringing in new products will likely help its success. In 2026, its share price target would be ₹1705, as per stock market analysts.

According to stock market analysts, its share price would be between ₹952 to ₹1705 in 2026.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	952	1705

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	982	1177
February	971	1200
March	952	1268
April	987	1335
May	1058	1374
June	1154	1400
July	1254	1435
August	1312	1458
September	1387	1487
October	1412	1558
November	1474	1663
December	1525	1705

Share Price Target 2027

This company is expected to keep growing in the pharmaceutical industry, especially with its focus on important medicines like cancer and HIV treatments. The company is expanding its business globally, and its strong efforts in research and development could lead to growth. But also market conditions and competition in the healthcare industry might present challenges, the company’s dedication to innovation and making high-quality medicines will likely help its share price continue to rise. In 2027 its share price target would be ₹1220 as per our analysis.

By our prediction, its share price would be between ₹590 to ₹1220 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	590	1220

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	920	1079
February	810	865
March	710	757
April	632	678
May	590	655
June	628	725
July	678	780
August	738	860
September	823	968
October	928	1056
November	1011	1180
December	1145	1220

Share Price Target 2028

The company’s work in increasing its production and growing its market share in making Active Pharmaceutical Ingredients will be important for its stock performance. The company’s partnerships and new products can help it become stronger in the industry. By continuing to enter new markets and investing in advanced research, Laurus Labs is expected to attract more investors and keep growing steadily. So in 2028, its share price target would be ₹1360 as per our analysis.

By our prediction, its share price would be between ₹680 to ₹1360 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	680	1360

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1145	1238
February	1011	1046
March	932	975
April	866	879
May	768	789
June	680	762
July	738	860
August	790	978
September	910	1078
October	1038	1176
November	1127	1278
December	1245	1360

Share Price Target 2029

Its strong position in the HIV/AIDS treatment market and partnerships with international companies will likely improve its reputation and profits. The company is expected to see long-term benefits from its investments in technology, production, and research. If the company continues to take advantage of the growing healthcare demand and adjusts to new regulations, its share price is likely to rise, showing its strong market presence and good financial performance. In 2029, its share price target would be ₹1470 as per our analysis.

By our prediction, its share price would be between ₹770 to ₹1470 in 2029.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	770	1470

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1245	1387
February	1121	1174
March	1021	1078
April	910	955
May	828	845
June	770	830
July	790	858
August	825	990
September	964	1172
October	1090	1287
November	1256	1390
December	1356	1470

Laurus Labs Share Price Target 2030

It makes a variety of products including APIs and advanced ingredients for important health treatments, beauty products, and enzyme solutions for industrial use. The company is known for its new ideas, high quality, and focus on customer needs. Its focus on research and development has helped it earn many patents, making it a top company in the industry. By 2030, its share price target would be ₹1694 as per technical analysis and the company’s status.

In 2030, its share price would be between ₹900 to ₹1694 as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	900	1694

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1356	1488
February	1221	1264
March	1120	1138
April	1010	1046
May	900	990
June	950	1070
July	987	1125
August	1057	1258
September	1190	1385
October	1278	1458
November	1312	1588
December	1543	1694

Share Price Target 2040

The company has shown consistent growth in past, which successfully provides a good amount of return to its long-term investors. The company’s ability to adjust itself to market challenges reflects its strong position in the pharmaceutical industry. With technological advancements and increasing global demand, the company working hard. The company is well-positioned to take advantage of increasing and has the potential for expansion the company in the coming years. In 2040, its share price target would be ₹3541 to the expert’s analysis.

As per our experts, its share price would be between ₹2845 to ₹3541 in 2040.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	2845	3541

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	2845	2974
February	2870	2997
March	2960	3068
April	3010	3099
May	3065	3128
June	3090	3165
July	3128	3180
August	3156	3256
September	3210	3378
October	3346	3459
November	3410	3519
December	3490	3541

Share Price Target 2050

It makes complex ingredients for important medicines and develops final products, especially for ARVs and cancer treatments. The company also provides research and manufacturing services to global pharmaceutical companies. The company holds a strong position in the ARV market, which is expected to grow due to increasing demand worldwide. Also, Its partnerships with international pharmaceutical companies boost its market presence and reputation. In 2050, its share price target would be ₹6635 as per our expert’s prediction.

By 2050, its share price will be between ₹5841 to ₹6635 as per our expert team.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	5841	6635

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	5841	5974
February	5876	6030
March	5968	6054
April	6010	6146
May	6121	6187
June	6146	6232
July	6198	6378
August	6257	6457
September	6378	6480
October	6423	6510
November	6456	6580
December	6538	6635

Should I Buy Laurus Labs Stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	952	1705
2027	590	1220
2028	680	1360
2029	770	1470
2030	900	1694
2040	2845	3541
2050	5841	6635

The share price has been continuously rising over the last six months, showing that investors trust the stock. it works in fast-growing healthcare areas and has a strong global presence. They have improved their manufacturing and offer a good range of generic active pharmaceutical ingredients (APIs). Also, the company records an increase in sales and profits compared to last year, indicating the company is making the most of market opportunities. Overall, many investors might find Laurus Labs a good investment choice.

Laurus Labs Earning Results

Mcap Full (Cr.)	24,283.74
Turnover (Cr.)	1.98
TTQ (Lakh)	0.44
EPS (TTM)	4.44
CEPS (TTM)	10.97
ROE	5.69
Face Value	2.00
NPM %	2.58
OPM %	15.28
Cash EPS	2.22
EPS	0.53
Net Profit(Cr.)	28.78
Revenue(Cr.)	1,116.93

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
169.25	6.09	0.17%	51.50	6.58	0.48%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Laurus Labs Ltd	156.24	6.09	0.17%
Sun Pharmaceutical Industries Ltd	47.53	6.78	0.71%
Cipla Ltd	29.86	4.59	0.85%
Torrent Pharmaceuticals Ltd	69.32	16.75	0.83%

Is Laurus Labs Stock Good to Buy? (Bull case & Bear case)

Bull Case:

• The company offers many different types of medicines, which helps protect it from risks if one product doesn’t do well.
• It is growing its factories and entering new markets, which could lead to more sales.
• It has been making more money every year, the past performance looks much good for this company.
• The pharmaceutical market is expected to grow because more people need healthcare.
• The company invests in research to create new and better products, helping it stay competitive.

Bear Case:

• Many other companies also make generic drugs, which can limit their profits.
• If the company depends too much on a few products, any drop in demand could create problems.
• Economic Factors: Changes in the economy, like currency shifts or healthcare policies, could affect sales.
• The drug industry has strict rules. If Laurus Labs doesn’t follow them, it could face serious issues.

Conclusion

In this article, we have given you all the main information about Laurus Labs. The company doing very well in its sector they also do business globally. Talking about its finances, it gave continuous good returns to its long-term Investors. So if you plan to invest or want to know more about this company then you should read the whole article to get a proper view for investing here or not.

FAQs